Active Surveillance, Ductal Carcinoma, and Staging | Answering YouTube Comments #2 | Mark Scholz, MD

Medical oncologist Mark Scholz, MD, answers YouTuber's "staging-themed" questions. Prostate cancer is a heterogeneous disease (meaning it behaves differently in different people) and staging refers to the process of characterizing an individual's cancer to determine the appropriate intensity of treatment—one that preserves as much quality of life as possible without risking morbidity and mortality from metastatic spread. In ambiguous cases, this balance will oftentimes require patient input about his own personal goals and wishes.

0:22 "I'm a 41-year-old with a Gleason score of 3+3 on the right side and 3+4 on the left side. Would radiation be a good treatment? I'm really scared of doing an operation. And what is the chance of the cancer coming back?"

2:08 "Do you have any suggestions on therapy for ductal carcinoma of the prostate?"

3:16 "Which patients should do a PET scan before deciding on a focal treatment like TULSA-PRO?"

5:08 "If prostate cancer is found in only 1 core out of 12, is that 5% or less? Would that qualify one for active surveillance?"

5:50 Can you reiterate the importance of getting a second opinion on the pathology report if there is a chance that it could affect the intensity of treatment?

6:59 How much do pathology second opinions on cost?

7:11 "I'm always confused why long term health is not considered for men who are in their 70s and 80s, like those in their 40s. Can you explain that deeper?..."

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD